Cargando…

MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients

Cytarabine is the primary chemotherapeutic agent used for treatment of acute myeloid leukemia (AML). Disease relapse after initial remission remains one of the most pressing therapeutic challenges in the treatment of AML. Relapsed disease is often resistant to cytarabine and subsequent salvage thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhise, Neha S., Chauhan, Lata, Shin, Miyoung, Cao, Xueyuan, Pounds, Stanley, Lamba, Vishal, Lamba, Jatinder K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729948/ https://www.ncbi.nlm.nih.gov/pubmed/26858643 http://dx.doi.org/10.3389/fphar.2015.00324

Ejemplares similares

Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
por: Stockard, Bradley, et al.
Publicado: (2021)

MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia
por: Bhise, Neha S., et al.
Publicado: (2019)

DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
por: Lamba, Jatinder K., et al.
Publicado: (2020)

Global Proteomic Profiling of Pediatric AML: A Pilot Study
por: Nguyen, Nam H. K., et al.
Publicado: (2021)

Identification of suitable reference genes for hepatic microRNA quantitation
por: Lamba, Vishal, et al.
Publicado: (2014)

Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML
por: Bargal, Salma A., et al.
Publicado: (2018)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML
por: Nguyen, Nam H. K., et al.
Publicado: (2022)

CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints
por: Cao, Xueyuan, et al.
Publicado: (2016)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

Serum Exosome MicroRNA as a Minimally-Invasive Early Biomarker of AML
por: Hornick, Noah I., et al.
Publicado: (2015)

Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity
por: Chauhan, Lata, et al.
Publicado: (2015)

How mRNA is misspliced in acute myelogenous leukemia (AML)?
por: Mohamed, Aminetou Mint, et al.
Publicado: (2014)

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
por: Johnson, Daniel T., et al.
Publicado: (2021)

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
por: Nielsen, Torsten H., et al.
Publicado: (2013)

The Aryl Hydrocarbon Receptor Pathway: A Key Component of the microRNA-Mediated AML Signalisome
por: Rager, Julia E., et al.
Publicado: (2012)

Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients
por: Pavlovic, Djordje, et al.
Publicado: (2021)

MicroRNAs Distinguish Cytogenetic Subgroups in Pediatric AML and Contribute to Complex Regulatory Networks in AML-Relevant Pathways
por: Daschkey, Svenja, et al.
Publicado: (2013)

Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients
por: SHIBAYAMA, YOSHIHIKO, et al.
Publicado: (2015)

Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins
por: Bauer, Marcus, et al.
Publicado: (2020)

CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML
por: Liu, Haoyu, et al.
Publicado: (2022)

MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance
por: Reichelt, Paula, et al.
Publicado: (2023)

Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice
por: Zheng, Jie, et al.
Publicado: (2015)

Measures of Association for Identifying MicroRNA-mRNA Pairs of Biological Interest
por: Jayaswal, Vivek, et al.
Publicado: (2012)

Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene
por: Li, Li, et al.
Publicado: (2017)

Research progress on microRNA in gout
por: Xie, Jing, et al.
Publicado: (2022)

Novel forms of Paired-like homeodomain transcription factor 2 (PITX2): Generation by alternative translation initiation and mRNA splicing
por: Lamba, Pankaj, et al.
Publicado: (2008)

Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations
por: Yang, Li, et al.
Publicado: (2019)

Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers
por: Salas, Maribel, et al.
Publicado: (2020)

MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells
por: Liu, Mei, et al.
Publicado: (2014)

Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins
por: Harden, Mallory E., et al.
Publicado: (2017)

Novel MicroRNA Candidates and miRNA-mRNA Pairs in Embryonic Stem (ES) Cells
por: Gu, Peili, et al.
Publicado: (2008)

Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2015)

AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
por: Gardini, Alessandro, et al.
Publicado: (2008)

Hepatic microRNAome reveals potential microRNA-mRNA pairs association with lipid metabolism in pigs
por: Liu, Jingge, et al.
Publicado: (2019)

Antibody response to mRNA vaccination for COVID-19 in patients with AML receiving hypomethylating agents alone or with venetoclax
por: Candoni, Anna, et al.
Publicado: (2022)

The role of the proteasome in AML
por: Csizmar, C M, et al.
Publicado: (2016)

Maintenance Therapy in AML
por: Reville, Patrick K., et al.
Publicado: (2021)

MicroRNA Involved in Inflammation: Control of Eicosanoid Pathway
por: Ochs, Meike J., et al.
Publicado: (2011)

Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
por: Bardin, Pauline, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pu08h2a30c7ng6h8kn5dcv189m